Adicet Bio, Inc. (ACET) annual balance sheet — 18-year assets, liabilities & equity history
Adicet Bio, Inc. (ACET) balance sheet — 18-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 | Jun'09 | Jun'08 |
|---|
| Total Current Assets | 103.44M | 160.93M | 180.14M | 162.27M | 261.04M | 282.44M | 100.34M | 64.19M | 109.53M | 54.23M | 352.66M | 310.31M | 276.35M | 218.3M | 191.97M | 198.62M | 195.55M | 171.65M | 193.78M |
| Cash & Short-Term Investments | 100.94M | 158.53M | 176.3M | 159.71M | 257.66M | 277.54M | 94.61M | 62.4M | 108.03M | 53.35M | 67.71M | 37.44M | 43.64M | 35.38M | 26.38M | 29.61M | 31.18M | 58.3M | 47.06M |
| Cash Only | 100.94M | 38.92M | 56.49M | 159.71M | 257.66M | 277.54M | 84.33M | 10.61M | 7.04M | 53.35M | 66.83M | 34.02M | 42.9M | 33.23M | 24.86M | 28.66M | 30.85M | 57.76M | 46.52M |
| Short-Term Investments | 0 | 119.61M | 119.81M | 0 | 0 | 0 | 10.28M | 51.79M | 100.99M | 0 | 881K | 3.42M | 746K | 2.14M | 1.52M | 943K | 335K | 541K | 548K |
| Accounts Receivable | 0 | 342K | 0 | 0 | 435K | 214K | 2.73M | 935K | 0 | 0 | 167.61M | 161.52M | 122.69M | 90.11M | 74.74M | 83.73M | 74.67M | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | 6.35 | 8.03 | 55.68 | 342.99 | - | - | 111.85 | 115.56 | 89.62 | 65.82 | 61.39 | 74.11 | 78.63 | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 136.39M | 98.11M | 95.6M | 100.68M | 83.85M | 84.69M | 77.43M | 74.86M | 54.4M | 71.11M |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | 1000K | 87.02 | 88.23 | 91.55 | 76.24 | 85.3 | 81.55 | 93.42 | 74.36 | 88.8 |
| Other Current Assets | 2.5M | 320K | 474K | 457K | 336K | 2K | 363K | 179K | 15K | 84K | 19.23M | 15.76M | 9.33M | 8.97M | 6.16M | 7.84M | 14.84M | 58.94M | 75.61M |
| Total Non-Current Assets | 25.5M | 31.43M | 40.08M | 45.02M | 69.65M | 56.5M | 53.5M | 17.4M | 405K | 968K | 188.12M | 179.46M | 191.63M | 105.13M | 107.31M | 96.38M | 21M | 17.63M | 11.71M |
| Property, Plant & Equipment | 0 | 28.48M | 36.75M | 44.2M | 48.98M | 35M | 25.86M | 2.12M | 321K | 39K | 10.04M | 10.46M | 11.57M | 11.41M | 11.71M | 12.1M | 6.91M | 4.25M | 4.31M |
| Fixed Asset Turnover | 0.00x | - | - | - | 0.51x | 0.28x | 0.69x | 0.47x | 25.49x | 14321.13x | 54.46x | 48.79x | 43.18x | 43.79x | 37.97x | 34.10x | 50.14x | 75.93x | 83.49x |
| Goodwill | 0 | 0 | 0 | 0 | 19.46M | 19.46M | 20.09M | 0 | 0 | 236.97M | 67.87M | 67.87M | 66.52M | 33.53M | 33.49M | 33.63M | 1.73M | 1.86M | 1.99M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 1.19M | 0 | 0 | 285.08M | 79.07M | 79M | 87.95M | 40.83M | 45.25M | 50.66M | 12.36M | 11.52M | 5.42M |
| Long-Term Investments | 5.74M | 2.87M | 0 | 0 | 0 | 0 | 4.53M | 10.59M | 84K | -541.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 25.5M | 76K | 3.33M | 822K | 1.21M | 2.04M | 1.84M | 4.69M | 0 | 929K | 13.08M | 12.17M | 13.98M | 11.31M | 12.14M | 0 | 0 | 0 | 0 |
| Total Assets | 128.95M | 192.35M | 220.22M | 207.29M | 330.69M | 338.94M | 153.84M | 81.59M | 109.94M | 55.19M | 540.78M | 489.77M | 467.98M | 323.43M | 299.28M | 294.99M | 216.56M | 189.27M | 205.5M |
| Asset Turnover | 0.00x | - | - | - | 0.08x | 0.03x | 0.12x | 0.01x | 0.07x | 10.12x | 1.01x | 1.04x | 1.07x | 1.54x | 1.48x | 1.40x | 1.60x | 1.70x | 1.75x |
| Asset Growth % | -41.39% | -12.65% | 6.23% | -37.31% | -2.43% | 120.33% | 88.55% | -25.79% | 99.19% | -89.79% | 10.41% | 4.66% | 44.69% | 8.07% | 1.45% | 36.22% | 14.41% | -7.9% | - |
| Total Current Liabilities | 17M | 21.53M | 19.39M | 19.29M | 19.71M | 16.32M | 22.48M | 14.87M | 5.72M | 5.5M | 98.91M | 125M | 118.52M | 89.91M | 73.64M | 83.19M | 74.63M | 46.94M | 65M |
| Accounts Payable | 0 | 4.74M | 4.83M | 2.63M | 4.4M | 3.26M | 1.55M | 1.05M | 538K | 1.51M | 0 | 54.96M | 48.72M | 39.22M | 42.01M | 44.61M | 39.97M | 25.13M | 43.48M |
| Days Payables Outstanding | 765.63 | 271.08 | - | - | - | - | - | - | 2.45K | 110.59K | - | 50.73 | 44.3 | 35.66 | 42.31 | 46.98 | 49.88 | 34.34 | 54.3 |
| Short-Term Debt | 2.85M | 0 | 0 | 0 | 0 | 0 | 1.22M | 0 | 0 | 14.47M | 197K | 10.2M | 8.34M | 11.71M | 6.71M | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 4.8M | 13.98M | 10.99M | 0 | 238K | 3.24M | 2.05M | 490K | 701K | 58K | 747K | 1.86M | 1.58M | 1.76M |
| Other Current Liabilities | 14.15M | 5.63M | 7.11M | 6.93M | 5.7M | 4.02M | 1.9M | 1.36M | 3.99M | -10.72M | 49.43M | 57.79M | 60.97M | 38.27M | 24.86M | 37.83M | 32.8M | 20.23M | 19.76M |
| Current Ratio | 6.09x | 7.47x | 9.29x | 8.41x | 13.25x | 17.31x | 4.46x | 4.32x | 19.16x | 9.86x | 3.57x | 2.48x | 2.33x | 2.43x | 2.61x | 2.39x | 2.62x | 3.66x | 2.98x |
| Quick Ratio | 6.09x | 7.47x | 9.29x | 8.41x | 13.25x | 17.31x | 4.46x | 4.32x | 19.16x | -14.93x | 2.57x | 1.72x | 1.48x | 1.50x | 1.46x | 1.46x | 1.62x | 2.50x | 1.89x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | 153.06 | 136.87 | 106.4 | 104.38 | 108.67 | 122.17 | - | - |
| Total Non-Current Liabilities | 9.25M | 11.61M | 14.22M | 17.83M | 18.64M | 19.49M | 21.53M | 127.09M | 19K | 407.97M | 134.08M | 107.57M | 108.8M | 33.77M | 52M | 6.25M | 33.59M | 20.74M | 19.95M |
| Long-Term Debt | 9.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.11M | 339.2M | 118.59M | 99.96M | 97.16M | 20.36M | 39.05M | 6.25M | 33.59M | 20.74M | 19.95M |
| Capital Lease Obligations | 32.6M | 11.55M | 14.1M | 17.7M | 18.53M | 19.38M | 20.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 125K | 0 | 0 | 7.33M | 9.14M | 66K | 6K | 6K | 8K | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 62K | 116K | 130K | 114K | 115K | 980K | 116.2M | -3.09M | -346.52M | 6.34M | 7.54M | 11.63M | 13.41M | 12.94M | 0 | 0 | 0 | 0 |
| Total Liabilities | 26.25M | 33.15M | 33.61M | 37.12M | 38.35M | 35.81M | 44.01M | 141.95M | 5.74M | 5.5M | 236.34M | 235.56M | 234.4M | 128.79M | 131.28M | 150.84M | 92.21M | 63.9M | 81.83M |
| Total Debt | 12.1M | 14.74M | 17.23M | 20.92M | 21.02M | 20.94M | 21.64M | 0 | 3.11M | 353.67M | 118.79M | 110.16M | 105.5M | 32.07M | 45.77M | 55M | 33.59M | 20.74M | 19.95M |
| Net Debt | -88.84M | -24.18M | -39.26M | -138.79M | -236.63M | -256.6M | -62.69M | -10.61M | -3.93M | 300.32M | 51.96M | 76.14M | 62.6M | -1.16M | 20.9M | 26.33M | 2.74M | -37.02M | -26.57M |
| Debt / Equity | 0.12x | 0.09x | 0.09x | 0.12x | 0.07x | 0.07x | 0.20x | - | 0.03x | 7.12x | 0.39x | 0.43x | 0.45x | 0.16x | 0.27x | 0.34x | 0.24x | 0.15x | 0.14x |
| Debt / EBITDA | -0.13x | - | - | - | - | - | - | - | - | - | 10.03x | 2.10x | 2.55x | 0.78x | 1.42x | 2.49x | 2.75x | 1.51x | 0.84x |
| Net Debt / EBITDA | 0.97x | - | - | - | - | - | - | - | - | - | 4.39x | 1.45x | 1.51x | -0.03x | 0.65x | 1.19x | 0.22x | -2.69x | -1.12x |
| Interest Coverage | -1563.17x | -3243.53x | -29279.50x | -5705.32x | -871.38x | -351.98x | -293.72x | - | - | -4.83x | -0.00x | 22.27x | 17.28x | 17.28x | 10.42x | 11.80x | 45.36x | 130.92x | 154.03x |
| Total Equity | 102.7M | 159.21M | 186.61M | 170.18M | 292.34M | 303.13M | 109.83M | -60.37M | 104.2M | 49.69M | 304.44M | 254.21M | 233.58M | 194.64M | 168M | 160.82M | 139.64M | 141.57M | 140.41M |
| Equity Growth % | -43.75% | -14.68% | 9.66% | -41.79% | -3.56% | 176.01% | 281.94% | -157.93% | 109.7% | -83.68% | 19.76% | 8.83% | 20.01% | 15.86% | 4.47% | 15.17% | -1.36% | 0.83% | - |
| Book Value per Share | 9.56 | 23.10 | 33.98 | 63.26 | 113.86 | 156.70 | 240.06 | -52.04 | 55.95 | 29.47 | 173.68 | 162.74 | 155.60 | 129.66 | 114.58 | 112.68 | 101.23 | 103.64 | 103.53 |
| Total Shareholders' Equity | 102.7M | 159.21M | 186.61M | 170.18M | 292.34M | 303.13M | 109.83M | -60.37M | 104.2M | 49.69M | 304.44M | 254.21M | 233.58M | 194.64M | 168M | 160.82M | 139.64M | 141.57M | 140.41M |
| Common Stock | 1K | 10K | 8K | 4K | 4K | 4K | 2K | 0 | 3K | 1K | 296K | 292K | 288K | 278K | 269K | 266K | 256K | 256K | 256K |
| Retained Earnings | -675.18M | -614.7M | -497.89M | -380.77M | -238.11M | -168.32M | -106.33M | -69.65M | -71.39M | -33.78M | 194.8M | 167.21M | 140.77M | 118.61M | 102.34M | 90.71M | 86.96M | 85.45M | 81.78M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -175K | 102K | 16K | 0 | 0 | 0 | 24K | 23K | -41K | -5.11M | -6.33M | -7.1M | 5.37M | 2.9M | 1.32M | 7.74M | 953K | 7.53M | 13.11M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying ACET stock.
As of 2025, Adicet Bio, Inc. (ACET) had total assets of $192.4M including $160.9M in current assets.
Adicet Bio, Inc. (ACET) carries total debt of $14.7M, offset by $158.5M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Adicet Bio, Inc. (ACET) has total shareholders' equity (book value) of $159.2M ($23.10 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Adicet Bio, Inc. (ACET) reported a current ratio of 7.47x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.